79 related articles for article (PubMed ID: 1818304)
1. The SCID mouse.
Pla M; Mahouy G
Nouv Rev Fr Hematol (1978); 1991; 33(6):489-91. PubMed ID: 1818304
[TBL] [Abstract][Full Text] [Related]
2. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells.
Jones RE; Bourdette DN; Whitham RH; Offner H; Vandenbark AA
J Immunol; 1993 May; 150(10):4620-9. PubMed ID: 8097758
[TBL] [Abstract][Full Text] [Related]
3. Xenogeneic PBL-scid mice: their potential and current limitations.
Greenwood JD
Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
[TBL] [Abstract][Full Text] [Related]
4. The SCID mouse mutant: definition, characterization, and potential uses.
Bosma MJ; Carroll AM
Annu Rev Immunol; 1991; 9():323-50. PubMed ID: 1910681
[TBL] [Abstract][Full Text] [Related]
5. SCID mouse as a model for transplantation studies.
Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
[TBL] [Abstract][Full Text] [Related]
6. The mouse severe combined immune deficiency (scid) mutation is closely linked to the B-cell-specific developmental genes VpreB and lambda 5.
Miller RD; Ozaki JH; Riblet R
Genomics; 1993 Jun; 16(3):740-4. PubMed ID: 8100803
[TBL] [Abstract][Full Text] [Related]
7. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
[TBL] [Abstract][Full Text] [Related]
8. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
9. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
10. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.
Beamer WG; Shultz KL; Tennent BJ; Shultz LD
Cancer Res; 1993 Aug; 53(16):3741-6. PubMed ID: 8339285
[TBL] [Abstract][Full Text] [Related]
11. Host origin of follicular dendritic cells induced in the spleen of SCID mice after transfer of allogeneic lymphocytes.
Yoshida K; Kaji M; Takahashi T; van den Berg TK; Dijkstra CD
Immunology; 1995 Jan; 84(1):117-26. PubMed ID: 7890295
[TBL] [Abstract][Full Text] [Related]
12. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.
Dorshkind K; Keller GM; Phillips RA; Miller RG; Bosma GC; O'Toole M; Bosma MJ
J Immunol; 1984 Apr; 132(4):1804-8. PubMed ID: 6607948
[TBL] [Abstract][Full Text] [Related]
13. Reversion of the SCID phenotype by human T cell grafts. Development of cross-species immunocompetence.
Donjon CM; Morkowski H; Cheung RK; Leeder JS; Dosch HM
J Immunol; 1993 Dec; 151(11):5948-54. PubMed ID: 8245439
[TBL] [Abstract][Full Text] [Related]
14. Characterization of B lymphocyte lineage progenitor cells from mice with severe combined immune deficiency disease (SCID) made possible by long term culture.
Witte PL; Burrows PD; Kincade PW; Cooper MD
J Immunol; 1987 Apr; 138(8):2698-705. PubMed ID: 3104473
[TBL] [Abstract][Full Text] [Related]
15. Fas system-mediated apoptosis suppresses lymphopoiesis.
Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
18. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
19. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
Zeng QH; Wang W; Liu T; Shi Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
[TBL] [Abstract][Full Text] [Related]
20. The SCID mouse: relevance as an animal model system for studying human disease.
Hendrickson EA
Am J Pathol; 1993 Dec; 143(6):1511-22. PubMed ID: 8256843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
